80 related articles for article (PubMed ID: 1300557)
1. [Influence of long-term hemodialysis treatment on total and free thyroxine serum concentration in patients with chronic renal failure].
Drabczyk R; Grzeszczak W; Trelewicz P
Pol Arch Med Wewn; 1992 Dec; 88(6):359-67. PubMed ID: 1300557
[TBL] [Abstract][Full Text] [Related]
2. [Influence of long term hemodialysis treatment on total, free and reverse triiodothyronine serum concentration in patients with chronic renal failure].
Drabczyk R; Grzeszczak W; Trelewicz P
Pol Arch Med Wewn; 1992 Dec; 88(6):368-80. PubMed ID: 1300558
[TBL] [Abstract][Full Text] [Related]
3. [Influence of long term hemodialysis treatment on TSH secretion in patients with chronic renal failure].
Drabczyk R; Grzeszczak W; Trelewicz P
Pol Arch Med Wewn; 1992 Dec; 88(6):381-91. PubMed ID: 1300559
[TBL] [Abstract][Full Text] [Related]
4. [Influence of long term dialysis therapy on function of the pituitary-adrenal axis in patients with chronic renal failure].
Dolińska-Laskoś C; Grzeszczak W; Zukowska-Szczechowska E
Pol Arch Med Wewn; 1993 Apr; 89(4):275-85. PubMed ID: 8394575
[TBL] [Abstract][Full Text] [Related]
5. Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis.
Ross RJ; Goodwin FJ; Houghton BJ; Boucher BJ
Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():156-60. PubMed ID: 3923894
[TBL] [Abstract][Full Text] [Related]
6. Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure.
Iitaka M; Kawasaki S; Sakurai S; Hara Y; Kuriyama R; Yamanaka K; Kitahama S; Miura S; Kawakami Y; Katayama S
Clin Endocrinol (Oxf); 1998 Jun; 48(6):739-46. PubMed ID: 9713563
[TBL] [Abstract][Full Text] [Related]
7. Plasma free thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement.
Nishikawa M; Ogawa Y; Yoshikawa N; Yoshimura M; Toyoda N; Shouzu A; Inada M
Endocr J; 1996 Oct; 43(5):487-93. PubMed ID: 8980887
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone profiles in patients with chronic renal failure on conservative management and regular haemodialysis.
Kayima JK; Otieno LS; Gitau W; Mwai S
East Afr Med J; 1992 Jun; 69(6):333-6. PubMed ID: 1505421
[TBL] [Abstract][Full Text] [Related]
9. [Effect of many years of hemodialysis therapy on FSH secretion induced by luliberin in men with chronic renal failure].
Starzyk J; Grzeszczak W; Kowalski D
Wiad Lek; 1993 Apr; 46(7-8):286-91. PubMed ID: 8249417
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).
Chang SC; Thibodeaux JR; Eastvold ML; Ehresman DJ; Bjork JA; Froehlich JW; Lau C; Singh RJ; Wallace KB; Butenhoff JL
Toxicology; 2008 Jan; 243(3):330-9. PubMed ID: 18063289
[TBL] [Abstract][Full Text] [Related]
11. Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure.
Okabayashi T; Takeda K; Kawada M; Kubo Y; Nakamura S; Chikamori K; Terao N; Hashimoto K
Clin Chem; 1996 Oct; 42(10):1616-20. PubMed ID: 8855144
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of the basal and stimulated serum level of thyroid stimulating hormone and determination of thyroxine, thyroxine- binding capacity and free thyroxine index in females with chronic uremia].
Rudolf K; Rudolf H; Rüting M; Falkenhagen D
Z Gesamte Inn Med; 1988 Oct; 43(20):590-2. PubMed ID: 3145649
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum thyrotropin levels using sensitive immunoradiometricassays in patients with chronic renal failure: alterations suggesting an intact pituitary thyroid axis.
Joseph LJ; Desai KB; Mehta HJ; Mehta MN; Almeida AF; Acharya VN; Samuel AM
Thyroidology; 1993 Aug; 5(2):35-9. PubMed ID: 7522529
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of serum thyrotropin and thyroid hormone changes in fasting.
Spencer CA; Lum SM; Wilber JF; Kaptein EM; Nicoloff JT
J Clin Endocrinol Metab; 1983 May; 56(5):883-8. PubMed ID: 6403568
[TBL] [Abstract][Full Text] [Related]
15. Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: is there any difference?
Alsaran K; Sabry A; Alshahhat H; Babgy E; Alzahrani F
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):917-21. PubMed ID: 21912019
[TBL] [Abstract][Full Text] [Related]
16. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.
Lim VS; Fang VS; Katz AI; Refetoff S
J Clin Invest; 1977 Sep; 60(3):522-34. PubMed ID: 408377
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
[TBL] [Abstract][Full Text] [Related]
18. [Basal and TRH stimulated TSH secretion and determination of total thyroxine (T4). Thyroxine-binding capacity and free thyroxine index (FT4-I) in patients with chronic uremia].
Rudolf K; Kunkel S; Rudolf H; Falkenhagen D; Rüting M
Zentralbl Gynakol; 1988; 110(11):689-92. PubMed ID: 3137736
[TBL] [Abstract][Full Text] [Related]
19. Alterations of serum reverse triiodothyronine and thyroxine kinetics in chronic renal failure: role of nutritional status, chronic illness, uremia, and hemodialysis.
Kaptein EM; Feinstein EI; Nicoloff JT; Massry SG
Kidney Int Suppl; 1983 Dec; 16():S180-6. PubMed ID: 6588250
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-thyroid axis in patients with Alzheimer disease (AD).
Yong-Hong L; Xiao-Dong P; Chang-Quan H; Bo Y; Qing-Xiu L
J Investig Med; 2013 Mar; 61(3):578-81. PubMed ID: 23360840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]